関連する実験動画
Updated: Feb 17, 2026

06:38
Detection of Abnormal Prion Protein by Immunohistochemistry
Published on: May 5, 2023
3.8K
ブラジルのプリオン病の監視に関する批判的見解
Breno José Alencar Pires Barbosa1, Maria Luiza Vasconcelos Montenegro2, José Eriton Gomes da Cunha3
1Medical Science Center, Federal University of Pernambuco, Recife, Brazil.
Frontiers in neuroscience
|February 16, 2026
まとめ
ブラジル ブラジルはブラジルです.
科学分野:
- 神経科学は神経科学である.
- エピデミオロジー エピデミオロジー
- 公衆衛生は公衆衛生である.
背景:
- プリオン病 (PrD) は致命的で,急速に進行する神経変性疾患です.
- クルーツフェルト・ヤコブ病 (CJD) は,PWDの最も一般的なサブタイプです.
- ブラジルの保健省 (MH) は2005年にCJDの監視を確立したが,信頼できるデータベースの作成に課題に直面している.
研究 の 目的:
- ブラジルのプリオン病の監視システムを分析するために.
- ブラジルのCJDの流行病学的プロフィールを理解するために.
主な方法:
- 遡及的・記述的研究.
- 2005年から2021年までのCJD監視の流行病学的記録の分析.
- MHの流行病学ブレーチン (2022) から得られたデータです.
主要な成果:
- 主に南東,南,北東の地域で,CjDの疑わしい症例が1,576件報告されました.
- 主要な年齢層: 55-74歳 (60.2%).
- 確認された症例: 34.7% (65.6% 検査, 29.4% 臨床-疫学).
結論:
- ブラジルのCJD症例の報告不足が顕著で,報告された数値に対して3,200件の症例が予想されています.
- データベースの設計とドキュメントの不一致によるMHデータ制限は,正確なPrDプロファイリングを妨げます.
- ブラジルのPrDの監視は,専用のCJDデータベースと正確なデータ管理を含む改善が必要です.
関連する概念動画
Principles of Disease Surveillance
591
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
591
Bias in Epidemiological Studies
1.4K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.4K
Causality in Epidemiology
1.7K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.7K
Prevalence and Incidence
1.9K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.9K
Steps in Outbreak Investigation
610
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
610
Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K

